Ebba Holme Hansen

4.9k total citations
143 papers, 3.7k citations indexed

About

Ebba Holme Hansen is a scholar working on Pediatrics, Perinatology and Child Health, General Health Professions and Economics and Econometrics. According to data from OpenAlex, Ebba Holme Hansen has authored 143 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pediatrics, Perinatology and Child Health, 37 papers in General Health Professions and 29 papers in Economics and Econometrics. Recurrent topics in Ebba Holme Hansen's work include Pharmaceutical studies and practices (33 papers), Pharmacovigilance and Adverse Drug Reactions (20 papers) and Pharmaceutical Economics and Policy (19 papers). Ebba Holme Hansen is often cited by papers focused on Pharmaceutical studies and practices (33 papers), Pharmacovigilance and Adverse Drug Reactions (20 papers) and Pharmaceutical Economics and Policy (19 papers). Ebba Holme Hansen collaborates with scholars based in Denmark, United States and Sweden. Ebba Holme Hansen's co-authors include Lise Aagaard, Bjørn Evald Holstein, Pernille Due, Lise Aagaard, Anette Andersen, Maria Lurenda Westergaard, Charlotte Glümer, Svend‎ Sabroe, Johanna Strandell and Rigmor Jensen and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Pain.

In The Last Decade

Ebba Holme Hansen

142 papers receiving 3.5k citations

Peers

Ebba Holme Hansen
Almut G. Winterstein United States
Ron M. C. Herings Netherlands
Eibert R. Heerdink Netherlands
Sue Jordan United Kingdom
Karen L. Rascati United States
Almut G. Winterstein United States
Ebba Holme Hansen
Citations per year, relative to Ebba Holme Hansen Ebba Holme Hansen (= 1×) peers Almut G. Winterstein

Countries citing papers authored by Ebba Holme Hansen

Since Specialization
Citations

This map shows the geographic impact of Ebba Holme Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebba Holme Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebba Holme Hansen more than expected).

Fields of papers citing papers by Ebba Holme Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ebba Holme Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebba Holme Hansen. The network helps show where Ebba Holme Hansen may publish in the future.

Co-authorship network of co-authors of Ebba Holme Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Ebba Holme Hansen. A scholar is included among the top collaborators of Ebba Holme Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ebba Holme Hansen. Ebba Holme Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jørgensen, Marit E., et al.. (2017). Long-term patterns of adherence to medication therapy among patients with type 2 diabetes mellitus in Denmark: The importance of initiation. PLoS ONE. 12(6). e0179546–e0179546. 22 indexed citations
2.
Nsabagasani, Xavier, et al.. (2016). ‘Better medicines for children’ within the Integrated Management of Childhood Illness framework: a qualitative inquiry in Uganda. Journal of Pharmaceutical Policy and Practice. 9(1). 22–22. 6 indexed citations
3.
Holstein, Bjørn Evald, Anette Andersen, Anastasios Fotiou, et al.. (2015). Adolescents' medicine use for headache: secular trends in 20 countries from 1986 to 2010. European Journal of Public Health. 25(suppl 2). 76–79. 12 indexed citations
4.
Nsabagasani, Xavier, et al.. (2015). Availability and utilization of the WHO recommended priority lifesaving medicines for under five-year old children in public health facilities in Uganda: a cross-sectional survey. Journal of Pharmaceutical Policy and Practice. 8(1). 18–18. 15 indexed citations
5.
Aagaard, Lise & Ebba Holme Hansen. (2013). Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011. BMC Pharmacology and Toxicology. 14(1). 30–30. 23 indexed citations
6.
Koushede, Vibeke, Ebba Holme Hansen, Anette Andersen, & Bjørn Evald Holstein. (2012). Young adults’ medicine use for headache: The combined effect of socioeconomic position and perceived stress, and the contribution of sense of coherence. Research in Social and Administrative Pharmacy. 8(6). 533–541. 13 indexed citations
7.
Aagaard, Lise, et al.. (2011). Adverse Drug Reactions Reported in the German Democratic Republic: A Retrospective Analysis of Reports to the WHO-ADR Database. Research at the University of Copenhagen (University of Copenhagen). 1(2). 60–74. 1 indexed citations
8.
9.
Trap, Birna, et al.. (2010). A new indicator based tool for assessing and reporting on good pharmacy practice.. Research at the University of Copenhagen (University of Copenhagen). 3(2). 4–11. 17 indexed citations
10.
Hansen, Ebba Holme. (2009). Integrated Care for Vulnerable Older People in Denmark. A Nudge Too Far? A Nudge at All? On Paying People to Be Healthy. 10(1). 29–33. 1 indexed citations
11.
Aagaard, Lise, Lars Nielsen, & Ebba Holme Hansen. (2009). Consumer Reporting of Adverse Drug Reactions. Drug Safety. 32(11). 1067–1074. 92 indexed citations
12.
Holstein, Bjørn Evald, Ebba Holme Hansen, Anette Andersen, & Pernille Due. (2007). Self‐rated health as predictor of medicine use in adolescence. Pharmacoepidemiology and Drug Safety. 17(2). 186–192. 28 indexed citations
13.
Hansen, Ebba Holme, et al.. (2007). Adolescents’ struggles with swallowing tablets: barriers, strategies and learning. Pharmacy World & Science. 30(1). 65–69. 56 indexed citations
14.
Hansen, Ebba Holme. (2004). The impact of flow injection on modern chemical analysis: has it fulfilled our expectations? And where are we going?. Talanta. 64(5). 1076–1083. 24 indexed citations
15.
Hansen, Ebba Holme, et al.. (2003). Prescription and non-prescription medicine use in Denmark: association with socio-economic position. European Journal of Clinical Pharmacology. 59(8-9). 677–684. 75 indexed citations
16.
Björnsdóttir, Ingunn, et al.. (1999). Quality assessment of drug sales data: the case of antibacterials in Iceland.. Pharmacy World & Science. 21(5). 221–226. 3 indexed citations
17.
Hansen, Ebba Holme, Lars Nørgaard, & Michael Pedersen. (1991). Optimization of flow-injection systems for determination of substrates by means of enzyme amplification reactions and chemiluminescence detection. Talanta. 38(3). 275–282. 36 indexed citations
18.
Hansen, Ebba Holme. (1990). Technology assessment of pharmaceuticals. The necessity of user perspective.. PubMed. 30(3). 313–27. 7 indexed citations
19.
Hansen, Ebba Holme, et al.. (1987). Clinical trials:towards a different model. Research at the University of Copenhagen (University of Copenhagen). 2 indexed citations
20.
Hansen, Ebba Holme, et al.. (1970). Environmental effects on nematodes in axenic culture.. Journal of Parasitology. 56(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026